Naloxone prescription fills and use by patients treated for opioid use disorder by telehealth
Background: It is unknown how many people in treatment for opioid use disorder (OUD) have naloxone, use naloxone, and what their perceptions and barriers to obtaining it are. Methods: This was a survey of patients treated in a large telehealth OUD program. Between December 6, 2023 and January 6, 202...
| Published in: | Drug and Alcohol Dependence Reports |
|---|---|
| Main Authors: | Scott G. Weiner, Emily N. Miller, Barbara Burke, Brian Clear |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772724624000283 |
Similar Items
Naloxone co-prescriptions for surgery patients prescribed opioids: A retrospective cohort study
by: Lyen C. Huang, et al.
Published: (2023-12-01)
by: Lyen C. Huang, et al.
Published: (2023-12-01)
Deregulating Naloxone to Combat Opioid-Related Overdoses in British Columbia
by: Kody Crowell
Published: (2019-09-01)
by: Kody Crowell
Published: (2019-09-01)
Longitudinal evaluation examining implementation and sustainment of an opioid overdose education and naloxone distribution among veterans who are unstably housed
by: Sarah J. Javier, et al.
Published: (2025-08-01)
by: Sarah J. Javier, et al.
Published: (2025-08-01)
Assessment of knowledge and behaviors of an opioid overdose education and naloxone distribution program during the coronavirus disease 2019 pandemic
by: Alexis E. Horace, et al.
Published: (2025-02-01)
by: Alexis E. Horace, et al.
Published: (2025-02-01)
Impact of California Statute on Naloxone Availability and Opioid Overdose Rates
by: Tara L. Gallant, BA, et al.
Published: (2023-09-01)
by: Tara L. Gallant, BA, et al.
Published: (2023-09-01)
Pharmacologic and Clinical Considerations of Nalmefene, a Long Duration Opioid Antagonist, in Opioid Overdose
by: Amber N. Edinoff, et al.
Published: (2021-10-01)
by: Amber N. Edinoff, et al.
Published: (2021-10-01)
Dispensing hope: leveraging distribution boxes to enhance low-barrier access to naloxone in healthcare settings
by: Nycole Kothe, et al.
Published: (2025-05-01)
by: Nycole Kothe, et al.
Published: (2025-05-01)
The implementation of take-home naloxone: Lessons learned from a 3-year take-home naloxone project in Germany
by: Simon Fleißner, et al.
Published: (2025-07-01)
by: Simon Fleißner, et al.
Published: (2025-07-01)
Design details for overdose education and take‐home naloxone kits: Codesign with family medicine, emergency department, addictions medicine and community
by: Kate Sellen, et al.
Published: (2022-10-01)
by: Kate Sellen, et al.
Published: (2022-10-01)
Broad-scale overdose education and naloxone distribution– 5-year follow-up of a regional program in Skåne County, Sweden
by: Katja Troberg, et al.
Published: (2025-06-01)
by: Katja Troberg, et al.
Published: (2025-06-01)
Implementation of an EMS‐based naloxone distribution program: A qualitative evaluation
by: Emily E. Ager, et al.
Published: (2024-10-01)
by: Emily E. Ager, et al.
Published: (2024-10-01)
Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
by: Zofia Kozak, et al.
Published: (2023-02-01)
by: Zofia Kozak, et al.
Published: (2023-02-01)
Opioid use and opioid overdose in the Netherlands – a 10 years retrospective study of naloxone administration in Dutch emergency departments
by: Bram Kok, et al.
Published: (2025-12-01)
by: Bram Kok, et al.
Published: (2025-12-01)
“It’s just another tool on my toolbelt”: New York state law enforcement officer experiences administering naloxone
by: Danielle Lloyd, et al.
Published: (2023-03-01)
by: Danielle Lloyd, et al.
Published: (2023-03-01)
Empowering Future Physicians: Enhancing Naloxone Competency Through Early Harm Reduction Training in Medical Education
by: Alexa Ovalles Lacruz, et al.
Published: (2025-02-01)
by: Alexa Ovalles Lacruz, et al.
Published: (2025-02-01)
What Is Known about Community Pharmacy-Based Take-Home Naloxone Programs and Program Interventions? A Scoping Review
by: Ashley Cid, et al.
Published: (2021-02-01)
by: Ashley Cid, et al.
Published: (2021-02-01)
Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review
by: Amina Moustaqim-Barrette, et al.
Published: (2021-03-01)
by: Amina Moustaqim-Barrette, et al.
Published: (2021-03-01)
Feasibility of paying people who use drugs cash to distribute naloxone within their networks
by: Nikki M. Lewis, et al.
Published: (2024-02-01)
by: Nikki M. Lewis, et al.
Published: (2024-02-01)
Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial
by: Hannah Ellerbroek, et al.
Published: (2022-09-01)
by: Hannah Ellerbroek, et al.
Published: (2022-09-01)
Superusers experiences in using naloxone to reverse opioid overdose - A qualitative study
by: K. Troberg, et al.
Published: (2022-06-01)
by: K. Troberg, et al.
Published: (2022-06-01)
A scoping review of factors that influence opioid overdose prevention for justice-involved populations
by: Christine E. Grella, et al.
Published: (2021-02-01)
by: Christine E. Grella, et al.
Published: (2021-02-01)
Naloxone reversal of the cardiorespiratory depressant effects of opioids and mixtures of opioids and stimulants in rats
by: Jacqueline M. Vazquez, et al.
Published: (2025-09-01)
by: Jacqueline M. Vazquez, et al.
Published: (2025-09-01)
Naloxone Decriminalization and Opioid Overdose Trends: A Comparative Study of Lucas County, Ohio and the U.S.
by: Margarita Kugotova, et al.
Published: (2025-10-01)
by: Margarita Kugotova, et al.
Published: (2025-10-01)
Patient perspectives on naloxone receipt in the emergency department: a qualitative exploration
by: Margaret Lowenstein, et al.
Published: (2022-08-01)
by: Margaret Lowenstein, et al.
Published: (2022-08-01)
“Naloxone? Not for me!” First cross-assessment by patients and healthcare professionals of the risk of opioid overdose
by: Aurélie Aquizerate, et al.
Published: (2024-01-01)
by: Aurélie Aquizerate, et al.
Published: (2024-01-01)
Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids
by: Albert Dahan, et al.
Published: (2024-02-01)
by: Albert Dahan, et al.
Published: (2024-02-01)
The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses
by: Robert M. Bohler, et al.
Published: (2023-03-01)
by: Robert M. Bohler, et al.
Published: (2023-03-01)
Pharmacy Students’ Perceptions and Stigma Surrounding Naloxone Use in Patients with Opioid Use Disorder: A Mixed Methods Evaluation
by: Alina Cernasev, et al.
Published: (2020-11-01)
by: Alina Cernasev, et al.
Published: (2020-11-01)
Understanding the Impact of Naloxone Distribution in Undeserved Communities
by: Chadwick Huss, et al.
Published: (2024-11-01)
by: Chadwick Huss, et al.
Published: (2024-11-01)
Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use
by: Erin L. Winstanley, et al.
Published: (2022-12-01)
by: Erin L. Winstanley, et al.
Published: (2022-12-01)
Are carfentanil and acrylfentanyl naloxone resistant?
by: Michael G. Feasel, et al.
Published: (2024-02-01)
by: Michael G. Feasel, et al.
Published: (2024-02-01)
Naloxone prescriptions among patients with a substance use disorder and a positive fentanyl urine drug screen presenting to the emergency department
by: Shawkut Amaan Ali, et al.
Published: (2023-10-01)
by: Shawkut Amaan Ali, et al.
Published: (2023-10-01)
Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
by: Minna M. Kanervo, et al.
Published: (2023-03-01)
by: Minna M. Kanervo, et al.
Published: (2023-03-01)
Nurses Supporting Harm Reduction: How Take-Home Naloxone is Conceived in the Context of Neoliberalism
by: Sibel Kusdemir, et al.
Published: (2023-12-01)
by: Sibel Kusdemir, et al.
Published: (2023-12-01)
Naloxone dosing by non-medical first-responders at opioid overdoses: findings from a qualitative interview study
by: Joanne Neale, et al.
Published: (2025-04-01)
by: Joanne Neale, et al.
Published: (2025-04-01)
Systemized approach to equipping medical students with naloxone: a student-driven initiative to combat the opioid crisis
by: Shahin A. Saberi, et al.
Published: (2024-03-01)
by: Shahin A. Saberi, et al.
Published: (2024-03-01)
Reported outcomes from a community naloxone training and distribution program
by: Kevin Frederiks, et al.
Published: (2025-06-01)
by: Kevin Frederiks, et al.
Published: (2025-06-01)
A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS
by: Nicola Metrebian, et al.
Published: (2023-08-01)
by: Nicola Metrebian, et al.
Published: (2023-08-01)
Disruptions to naloxone training among lay and occupational responders in Maryland during the emergence of COVID-19: Early impacts, recovery, and lessons learned
by: Himani Byregowda, et al.
Published: (2023-09-01)
by: Himani Byregowda, et al.
Published: (2023-09-01)
Over the counter naloxone nasal spray: A new hope for opioid crisis management in Pakistan
by: Zmarak Ahmed Khan, et al.
Published: (2025-02-01)
by: Zmarak Ahmed Khan, et al.
Published: (2025-02-01)
Similar Items
-
Naloxone co-prescriptions for surgery patients prescribed opioids: A retrospective cohort study
by: Lyen C. Huang, et al.
Published: (2023-12-01) -
Deregulating Naloxone to Combat Opioid-Related Overdoses in British Columbia
by: Kody Crowell
Published: (2019-09-01) -
Longitudinal evaluation examining implementation and sustainment of an opioid overdose education and naloxone distribution among veterans who are unstably housed
by: Sarah J. Javier, et al.
Published: (2025-08-01) -
Assessment of knowledge and behaviors of an opioid overdose education and naloxone distribution program during the coronavirus disease 2019 pandemic
by: Alexis E. Horace, et al.
Published: (2025-02-01) -
Impact of California Statute on Naloxone Availability and Opioid Overdose Rates
by: Tara L. Gallant, BA, et al.
Published: (2023-09-01)
